Nanosphere submits its flu test to FDA on new Verigene system
This article was originally published in Clinica
Executive Summary
Nanosphere has submitted a 510(k) application to the US FDA for its influenza and respiratory syncytial virus (RSV) test that will run on its next-generation Verigene SP system.